Wright Medical Group N.V. was a global medical device company focused on extremities and biologics. The company developed a portfolio of implants, instruments and next-generation biologics for the surgical treatment of conditions affecting the foot, ankle and upper extremities. It operated through an integrated model that combined product development, manufacturing and commercialization efforts aimed at orthopaedic surgeons and healthcare providers.
The company’s product line included joint replacement systems, fixation plates and screws, external fixation devices, and bone graft substitutes. Its extremities offerings comprised ankle replacement implants, intramedullary nails and locking plate systems designed for small joints. In the biologics segment, Wright Medical marketed collagen- and hyaluronic acid–based scaffolds, demineralized bone matrices and synthetic bone void fillers intended to support tissue regeneration and enhance postoperative healing.
Originally founded as an orthopaedic device manufacturer in the United States, Wright Medical Group restructured as a Dutch-incorporated entity in 2015 while retaining its operational headquarters in Memphis, Tennessee. Over its history, the company expanded its geographic reach to serve surgeons and healthcare facilities across North America, Europe, Asia-Pacific and select emerging markets. It grew its technology platform through a combination of internal research and development initiatives and targeted acquisitions aimed at strengthening its extremities and biologics portfolio.
In October 2019, Zimmer Biomet Holdings announced an agreement to acquire Wright Medical Group, and the transaction was completed in February 2021. Following the merger, Wright Medical’s products and technologies were integrated into Zimmer Biomet’s extremities and biologics offerings, enhancing the combined company’s position in the global orthopaedic device market.
AI Generated. May Contain Errors.
Free GCVRZ Stock Alerts